Why the study?
Blood lipid levels are closely related to cardiovascular prognosis, but the effect of serum LDL-C levels on long-term mortality in acute aortic dissection remained to be analyzed.
Is a lower admission LDL-C level associated with an increased risk of long-term mortality in patients with acute aortic dissection?
Is a lower admission LDL-C level associated with an increased risk of long-term mortality in patients with acute aortic dissection?
Lower admission LDL-C levels (<2.755 mmol/L) are independently associated with an increased risk of long-term mortality in patients with acute aortic dissection.
Low admission LDL-C may identify higher-risk AAD patients; leaves open causality and requires prospective validation.
Background: The level of blood lipid is closely related to prognosis in cardiovascular diseases. This study aims to analyze the effect of serum low-density lipoprotein cholesterol (LDL-C) levels on the long-term mortality in acute aortic dissection (AAD). A lower admission LDL-C level is associated with an increased risk of long-term mortality in AAD. Methods: We analyzed the data of 284 patients with AAD admitted to the First Affiliated Hospital of Shantou University Medical College from February 2016 to September 2019. Patients were followed up post-discharge. All patients were divided into either an LDL-C low-level group or an LDL-C high-level group according to the optimal cut-off point obtained by the receiver operating characteristic (ROC) curve. The endpoint outcome was long-term mortality in AAD. A survival analysis and Cox proportional hazards model were used. Results: According to the Youden index, the optimal cut-off point for LDL-C was 2.755 mmol/L. The Kaplan-Meier survival analysis curves showed that the long-term mortality of the LDL-C low-level group (<2.755 mmol/L) was significantly higher than that of the LDL-C high-level group (≥2.755 mmol/L) (log-rank χ2=13.912, P<0.001). After multivariate Cox regression analysis, LDL-C <2.755 mmol/L was still significantly associated with long-term mortality in AAD (HR=3.287, 95% CI: 1.637–6.600, P=0.001). In addition, cystatin C was also an independent risk factor for the long-term prognosis of AAD (HR=1.253, 95% CI: 1.057–1.486, P=0.009). Conclusions: A lower admission LDL-C level may be associated with an increased risk of long-term mortality in AAD.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: